- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Daito Pharmaceutical Co Ltd (4577)
Daito Pharmaceutical Co Ltd stock price live, this page displays TYO 4577 stock exchange data. View the 4577 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Daito Pharmaceutical Co Ltd real time stock price chart below.
What Is the Daito Pharmaceutical Co Ltd Stock Price Today?
The Daito Pharmaceutical Co Ltd stock price today is 1,366.0.
What Is the Stock Symbol for Daito Pharmaceutical Co Ltd?
The stock symbol for Daito Pharmaceutical Co Ltd is ""4577.""
What Stock Exchange Does Daito Pharmaceutical Co Ltd Trade On?
Daito Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Daito Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Daito Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4577 quote. (ISIN: JP3486150000)
What Is the Daito Pharmaceutical Co Ltd Stock Price Today?
The Daito Pharmaceutical Co Ltd stock price today is 1,366.0.
What Is the Stock Symbol for Daito Pharmaceutical Co Ltd?
The stock symbol for Daito Pharmaceutical Co Ltd is ""4577.""
What Stock Exchange Does Daito Pharmaceutical Co Ltd Trade On?
Daito Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Daito Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Daito Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4577 quote. (ISIN: JP3486150000)
Tokyo
Currency in JPY
1,366.0
-4.0(-0.29%)
Closed·
Fair Value
An estimate of a Daito Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,350.0
1,370.0
52 wk Range
970.0
2,293.0
4577 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Daito Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,350.01,370.0
52 wk Range
970.02,293.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4577 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Daito Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
1,400.0
Upside
+2.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Daito Pharmaceutical Co Ltd Company Profile
Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Compare 4577 to Peers and Sector
Metrics to compare | 4577 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4577PeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.9x | 16.6x | −0.5x | |
PEG Ratio | −1.33 | 0.05 | 0.00 | |
Price/Book | 0.8x | 1.5x | 2.6x | |
Price / LTM Sales | 0.8x | 2.0x | 3.3x | |
Upside (Analyst Target) | 2.5% | −3.1% | 47.0% | |
Fair Value Upside | Unlock | 6.0% | 6.1% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1,400.0
(+2.49% Upside)
Earnings
Latest Release
Jan 14, 2026
EPS / Forecast
18.08 / --
Revenue / Forecast
12.13B / 12.60B
FAQ
What Is the Daito Pharmaceutical (4577) Stock Price Today?
The Daito Pharmaceutical stock price today is 1,366.0.
What Stock Exchange Does Daito Pharmaceutical Trade On?
Daito Pharmaceutical is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Daito Pharmaceutical?
The stock symbol for Daito Pharmaceutical is "4577."
What Is the Daito Pharmaceutical Market Cap?
As of today, Daito Pharmaceutical market cap is 39.94B.
What Is Daito Pharmaceutical's Earnings Per Share (TTM)?
The Daito Pharmaceutical EPS (TTM) is 74.32.
When Is the Next Daito Pharmaceutical Earnings Date?
Daito Pharmaceutical will release its next earnings report on Apr 09, 2026.
From a Technical Analysis Perspective, Is 4577 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Daito Pharmaceutical Stock Split?
Daito Pharmaceutical has split 3 times.
How Many Employees Does Daito Pharmaceutical Have?
Daito Pharmaceutical has 1073 employees.
What is the current trading status of Daito Pharmaceutical (4577)?
As of 14 Feb 2026, Daito Pharmaceutical (4577) is trading at a price of 1,366.0, with a previous close of 1,370.0. The stock has fluctuated within a day range of 1,350.0 to 1,370.0, while its 52-week range spans from 970.0 to 2,293.0.
What Is Daito Pharmaceutical (4577) Price Target According to Analysts?
The average 12-month price target for Daito Pharmaceutical is JPY1,400.0, with a high estimate of JPY1400 and a low estimate of JPY1400. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +2.49% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.